Furthermore, analysis based on TCGA database which included 1043 breast cancer samples showed that enhanced GALNT6 expression was significantly associated with advanced pN stage (p = 0.033) and advanced pTNM stage (with a border line significance of p = 0.091) (Table 3 and Supplementary Table 2). Here, GALNT6 is linked to breast carcinoma.